Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market: By Product Type, Tissue Sealants, Adhesion Barriers, By Application, Trauma Cases), By End User, and Region Forecast 2020-2031
Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market size was valued at US$ 3,052.2 million in 2024 and is expected to reach US$ 5,333.5 million by 2031, growing at a significant CAGR of 8.3% from 2025-2031. owing to rising geriatric population across the globe coupled with growing demand for cardiovascular, orthopedic, digestive, and other surgical procedures expected to fuel consumption of market.
Moreover, well-established healthcare infrastructure and favorable reimbursement policies fuels the growth of the market. This report gives comprehensive outlook on surgical hemostats, tissue sealants and adhesion barriers across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. This report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, end-user, and region. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
In addition, this report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global surgical hemostats, tissue sealants and adhesion barriers products.
Study Period
2025-2031Base Year
2024CAGR
8.3%Largest Market
North-AmericaFastest Growing Market
Europe
Macroeconomic factors such as high unmet patient needs, government reimbursement plans, and strengthening of distribution network by key players in the surgical hemostats, internal tissue sealants and adhesion barriers market is another factor that is going to drive the market in future. Rapidly growing medical technology industry and cost-effectiveness of the treatment in Asia Pacific and Latin America regions fuels the growth of the market over the forecast period.
North America accounted for larger revenue share in global surgical hemostats, tissue sealants and adhesion barriers market with significant CAGR owing to presence of prominent players in the region and availability of favorable reimbursement policies and high adoption of advanced surgical procedures drives the growth of the market over the forecast period. Asia Pacific region is expected to grow with highest CAGR over the forecast period owing to presence of emerging economies such as China and India and rise in medical tourism for surgical procedures and well developed healthcare infrastructure and specialty clinics fuels the growth of the market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 3,052.2 million |
|
Market Size in 2031 |
US$ 5,333.5 million |
|
Market CAGR |
8.3% |
|
By Product Type |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The surgical hemostats tissue sealants and adhesion barriers market size was valued at US$ 3,052.2 million in 2024 and is expected to reach US$ 5,333.5 million by 2031, growing at a significant CAGR of 8.3% from 2025-2031.
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market key players Baxter, Ethicon, Inc., Braun Melsungen AG, Sanofi R. Bard, Inc. Integra Lifesciences Corporation Cryolife Inc. Tissuemed Ltd Cohera Medical, Inc. Pfizer Inc.
| 1.Executive Summary |
| 2.Global Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market Introduction |
| 2.1.Global Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market - Taxonomy |
| 2.2.Global Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market - Definitions |
| 2.2.1. Product Type |
| 2.2.2.Application |
| 2.2.3. End User |
| 2.2.4.Region |
| 3.Global Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Hemostats |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Tissue Sealants |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Adhesion Barriers |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Surgical Repair |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Trauma Cases |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ambulatory Surgical Centers |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Specialty Clinics |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America (U.S., Canada) |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe) |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa) |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America (U.S., Canada) Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Hemostats |
| 9.1.2.Tissue Sealants |
| 9.1.3.Adhesion Barriers |
| 9.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Surgical Repair |
| 9.2.2.Trauma Cases |
| 9.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Ambulatory Surgical Centers |
| 9.3.3.Specialty Clinics |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe) Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Hemostats |
| 10.1.2.Tissue Sealants |
| 10.1.3.Adhesion Barriers |
| 10.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Surgical Repair |
| 10.2.2.Trauma Cases |
| 10.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Ambulatory Surgical Centers |
| 10.3.3.Specialty Clinics |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific) Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Hemostats |
| 11.1.2.Tissue Sealants |
| 11.1.3.Adhesion Barriers |
| 11.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Surgical Repair |
| 11.2.2.Trauma Cases |
| 11.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Ambulatory Surgical Centers |
| 11.3.3.Specialty Clinics |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America) Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Hemostats |
| 12.1.2.Tissue Sealants |
| 12.1.3.Adhesion Barriers |
| 12.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Surgical Repair |
| 12.2.2.Trauma Cases |
| 12.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Ambulatory Surgical Centers |
| 12.3.3.Specialty Clinics |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa) Surgical Hemostats, Tissue Sealants and Adhesion Barriers Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Hemostats |
| 13.1.2.Tissue Sealants |
| 13.1.3.Adhesion Barriers |
| 13.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Surgical Repair |
| 13.2.2.Trauma Cases |
| 13.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Ambulatory Surgical Centers |
| 13.3.3.Specialty Clinics |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Baxter |
| 14.2.2.Ethicon, Inc. |
| 14.2.3.Braun Melsungen AG |
| 14.2.4.Sanofi |
| 14.2.5.R. Bard, Inc. |
| 14.2.6.Integra Lifesciences Corporation |
| 14.2.7.Cryolife Inc. |
| 14.2.8.Tissuemed Ltd |
| 14.2.9.Cohera Medical, Inc. |
| 14.2.10.Pfizer Inc. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
